Market Cap 2.50B
Revenue (ttm) 1.25B
Net Income (ttm) 63.23M
EPS (ttm) N/A
PE Ratio 15.14
Forward PE 14.77
Profit Margin 5.04%
Debt to Equity Ratio 0.61
Volume 409,100
Avg Vol 829,032
Day's Range N/A - N/A
Shares Out 54.53M
Stochastic %K 41%
Beta 0.90
Analysts Strong Sell
Price Target $62.67

Company Profile

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy...

Industry: Medical Devices
Sector: Healthcare
Phone: 44 20 3325 0660
Address:
20 Eastbourne Terrace, London, United Kingdom
Estimize
Estimize Jun. 17 at 2:00 PM
Wall St is expecting 0.87 EPS for $LIVN Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
0 · Reply
zoey1970
zoey1970 Jun. 13 at 3:21 PM
$MDT How Next-Gen Implants Are Making Seizure Prevention Smarter and Safer Than Ever An implantable chip could soon spot early epilepsy signals and intervene, significantly enhancing patients’ quality of life. At the heart of this innovation are Spiking Neural Networks (SNNs), a form of artificial intelligence that mimics the brain’s efficiency. These neuromorphic implantables, built on SNNs, mark notable progress toward energy-efficient AI, contrasting with traditional Artificial Neural Networks (ANNs) that operate nonstop like constant light sources. SNNs, in contrast, utilize event-triggered “spikes” (brief electrical pulses), activating only as needed and thereby slashing energy use—a vital advantage for medical tools. Read more here if interested...https://neuromorphiccore.ai/how-next-gen-implants-are-making-seizure-prevention-smarter-and-safer-than-ever/ $BSX $ABT $NPCE $LIVN
0 · Reply
MaverikIT
MaverikIT Jun. 10 at 2:29 PM
$LIVN +1.15 Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support
0 · Reply
MaverikIT
MaverikIT Jun. 10 at 1:46 PM
$LIVN +0.73
0 · Reply
swingingtech
swingingtech Jun. 9 at 9:11 PM
$LIVN https://wallstreetwaves.com/livn-surges-above-key-moving-average-signals-positive-momentum/
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 3:40 AM
$LIVN LivaNova is flying under the radar with explosive growth in heart-lung machines, epilepsy therapy, and sleep apnea treatment. Learn more here! https://biotechhealthx.com/biotech-news/wall-street-is-missing-this-hidden-medtech-gem-livanova-livn-could-be-a-2025-winner/
0 · Reply
DonCorleone77
DonCorleone77 Jun. 4 at 12:17 PM
$LIVN LivaNova initiates process with U.S. Centers for Medicare and Medicaid Services LivaNova announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services to seek reconsideration of national Medicare coverage for VNS Therapy in unipolar patients with treatment-resistant depression. The first step in the process for making a National Coverage Determination is the submission of a draft formal request for CMS reconsideration.
0 · Reply
JarvisFlow
JarvisFlow May. 20 at 4:15 PM
Wolfe Research updates rating for LivaNova ( $LIVN ) to Outperform, target set at 60.
0 · Reply
JarvisFlow
JarvisFlow May. 13 at 12:00 PM
Needham updates rating for LivaNova ( $LIVN ) to Buy, target set at 64.
0 · Reply
JarvisFlow
JarvisFlow May. 8 at 1:00 PM
Baird updates rating for LivaNova ( $LIVN ) to Outperform, target set at 55 → 61.
0 · Reply
Latest News on LIVN
LivaNova PLC (LIVN) Q1 2025 Earnings Call Transcript

May 11, 2025, 2:56 AM EDT - 5 weeks ago

LivaNova PLC (LIVN) Q1 2025 Earnings Call Transcript


LivaNova to Announce First-Quarter 2025 Results

Mar 26, 2025, 8:00 AM EDT - 2 months ago

LivaNova to Announce First-Quarter 2025 Results


LivaNova PLC (LIVN) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 7:10 PM EST - 3 months ago

LivaNova PLC (LIVN) Q4 2024 Earnings Call Transcript


LivaNova to Present at the Barclays Global Healthcare Conference

Feb 21, 2025, 9:00 AM EST - 4 months ago

LivaNova to Present at the Barclays Global Healthcare Conference


LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results

Jan 21, 2025, 9:00 AM EST - 5 months ago

LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results


LivaNova PLC (LIVN) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 2:30 PM EDT - 8 months ago

LivaNova PLC (LIVN) Q3 2024 Earnings Call Transcript


LivaNova Reports Third-Quarter 2024 Results

Oct 30, 2024, 6:00 AM EDT - 8 months ago

LivaNova Reports Third-Quarter 2024 Results


LivaNova: Economics Should Start Making Sustained Improvements

Oct 18, 2024, 3:45 AM EDT - 8 months ago

LivaNova: Economics Should Start Making Sustained Improvements


LivaNova Appoints Susan Podlogar as a New Director

Oct 8, 2024, 9:00 AM EDT - 9 months ago

LivaNova Appoints Susan Podlogar as a New Director


LivaNova to Announce Third-Quarter 2024 Results

Sep 25, 2024, 9:00 AM EDT - 9 months ago

LivaNova to Announce Third-Quarter 2024 Results


LivaNova to Present at the Baird Global Healthcare Conference

Aug 19, 2024, 9:00 AM EDT - 10 months ago

LivaNova to Present at the Baird Global Healthcare Conference


LivaNova PLC (LIVN) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 1:57 PM EDT - 11 months ago

LivaNova PLC (LIVN) Q2 2024 Earnings Call Transcript


LivaNova Reports Second-Quarter 2024 Results

Jul 31, 2024, 6:00 AM EDT - 11 months ago

LivaNova Reports Second-Quarter 2024 Results


LivaNova to Announce Second-Quarter 2024 Results

Jun 18, 2024, 9:00 AM EDT - 1 year ago

LivaNova to Announce Second-Quarter 2024 Results


LivaNova PLC (LIVN) Q1 2024 Earnings Call Transcript

May 1, 2024, 10:56 AM EDT - 1 year ago

LivaNova PLC (LIVN) Q1 2024 Earnings Call Transcript


LivaNova Reports First-Quarter 2024 Results

May 1, 2024, 6:00 AM EDT - 1 year ago

LivaNova Reports First-Quarter 2024 Results


LivaNova to Announce First-Quarter 2024 Results

Mar 21, 2024, 9:00 AM EDT - 1 year ago

LivaNova to Announce First-Quarter 2024 Results


LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript

Feb 21, 2024, 10:36 AM EST - 1 year ago

LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript


LivaNova Reports Fourth-Quarter and Full-Year 2023 Results

Feb 21, 2024, 6:00 AM EST - 1 year ago

LivaNova Reports Fourth-Quarter and Full-Year 2023 Results


LivaNova: Reaching End Of RECOVER And ANTHEM

Dec 26, 2023, 6:00 PM EST - 1 year ago

LivaNova: Reaching End Of RECOVER And ANTHEM


LivaNova PLC (LIVN) Q3 2023 Earnings Call Transcript

Nov 1, 2023, 1:26 PM EDT - 1 year ago

LivaNova PLC (LIVN) Q3 2023 Earnings Call Transcript


LivaNova Reports Third-Quarter 2023 Results

Nov 1, 2023, 6:00 AM EDT - 1 year ago

LivaNova Reports Third-Quarter 2023 Results


LivaNova Board Appoints J. Christopher Barry as New Director

Oct 6, 2023, 8:30 AM EDT - 1 year ago

LivaNova Board Appoints J. Christopher Barry as New Director


Estimize
Estimize Jun. 17 at 2:00 PM
Wall St is expecting 0.87 EPS for $LIVN Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
0 · Reply
zoey1970
zoey1970 Jun. 13 at 3:21 PM
$MDT How Next-Gen Implants Are Making Seizure Prevention Smarter and Safer Than Ever An implantable chip could soon spot early epilepsy signals and intervene, significantly enhancing patients’ quality of life. At the heart of this innovation are Spiking Neural Networks (SNNs), a form of artificial intelligence that mimics the brain’s efficiency. These neuromorphic implantables, built on SNNs, mark notable progress toward energy-efficient AI, contrasting with traditional Artificial Neural Networks (ANNs) that operate nonstop like constant light sources. SNNs, in contrast, utilize event-triggered “spikes” (brief electrical pulses), activating only as needed and thereby slashing energy use—a vital advantage for medical tools. Read more here if interested...https://neuromorphiccore.ai/how-next-gen-implants-are-making-seizure-prevention-smarter-and-safer-than-ever/ $BSX $ABT $NPCE $LIVN
0 · Reply
MaverikIT
MaverikIT Jun. 10 at 2:29 PM
$LIVN +1.15 Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support
0 · Reply
MaverikIT
MaverikIT Jun. 10 at 1:46 PM
$LIVN +0.73
0 · Reply
swingingtech
swingingtech Jun. 9 at 9:11 PM
$LIVN https://wallstreetwaves.com/livn-surges-above-key-moving-average-signals-positive-momentum/
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 8 at 3:40 AM
$LIVN LivaNova is flying under the radar with explosive growth in heart-lung machines, epilepsy therapy, and sleep apnea treatment. Learn more here! https://biotechhealthx.com/biotech-news/wall-street-is-missing-this-hidden-medtech-gem-livanova-livn-could-be-a-2025-winner/
0 · Reply
DonCorleone77
DonCorleone77 Jun. 4 at 12:17 PM
$LIVN LivaNova initiates process with U.S. Centers for Medicare and Medicaid Services LivaNova announced it has initiated the process with the U.S. Centers for Medicare and Medicaid Services to seek reconsideration of national Medicare coverage for VNS Therapy in unipolar patients with treatment-resistant depression. The first step in the process for making a National Coverage Determination is the submission of a draft formal request for CMS reconsideration.
0 · Reply
JarvisFlow
JarvisFlow May. 20 at 4:15 PM
Wolfe Research updates rating for LivaNova ( $LIVN ) to Outperform, target set at 60.
0 · Reply
JarvisFlow
JarvisFlow May. 13 at 12:00 PM
Needham updates rating for LivaNova ( $LIVN ) to Buy, target set at 64.
0 · Reply
JarvisFlow
JarvisFlow May. 8 at 1:00 PM
Baird updates rating for LivaNova ( $LIVN ) to Outperform, target set at 55 → 61.
0 · Reply
KabilSamir
KabilSamir May. 8 at 10:15 AM
0 · Reply
MaverikIT
MaverikIT May. 7 at 2:37 PM
@Tommojg $LIVN - nice ER
0 · Reply
Armonica423
Armonica423 May. 6 at 12:37 PM
$LIVN CYDY
0 · Reply
DonCorleone77
DonCorleone77 Apr. 2 at 10:58 AM
$ENOV $LIVN Enovis names Damien McDonald as CEO, succeeding Matt Trerotola Enovis (ENOV) announced the appointment of Damien McDonald as CEO, effective May 12. McDonald will also join the Enovis Board of Directors following the conclusion of the company's 2025 Annual Meeting of Stockholders on May 21. He will succeed Matt Trerotola, who previously announced his intention to retire as CEO and has informed the Board that he will not stand for re-election at the Annual Meeting. McDonald joins Enovis with more than 35 years of experience in the medical device industry. Most recently, he served as CEO of LivaNova (LIVN).
0 · Reply
NVDAMillionaire
NVDAMillionaire Mar. 26 at 11:28 AM
$LIVN VNS therapy looking promising. Neuromodulation segment showing strength. Eyeing potential Medicare coverage for depression treatment. Might increase position on next dip. standout article: https://beyondspx.com/article/livanova-plc-livn-navigating-challenges-and-capitalizing-on-growth-opportunities
0 · Reply
Estimize
Estimize Mar. 20 at 11:03 AM
Wall St is expecting 0.76 EPS for $LIVN Q1 [Reporting 04/30 BMO] http://www.estimize.com/intro/livn?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Mar. 17 at 1:00 PM
Needham has updated their rating for LivaNova ( $LIVN ) to Buy with a price target of 64.
0 · Reply
JarvisFlow
JarvisFlow Mar. 7 at 11:30 AM
Barclays has updated their rating for LivaNova ( $LIVN ) to Equal-Weight with a price target of 56.
0 · Reply
erevnon
erevnon Mar. 3 at 6:19 PM
Goldman Sachs maintains LivaNova $LIVN at Buy and lowers the price target from $64 to https://marketsblock.com/stock-upgrades-and-downgrades/
0 · Reply
JarvisFlow
JarvisFlow Mar. 3 at 2:56 PM
Goldman Sachs has updated their rating for LivaNova ( $LIVN ) to Buy with a price target of 55.
0 · Reply
MicsMugz
MicsMugz Feb. 26 at 10:44 PM
$LIVN Cheap yes but no movement buy but know movement
0 · Reply
RocketThief
RocketThief Feb. 26 at 9:44 PM
$LIVN so cheap
0 · Reply